$QCOR News Questcor raises quarterly dividend 20% 12:32

New Post Public Reply Private Reply Replies (0) Message Board

Jan 24, 2014 at 9:24 PM

$QCOR News

Questcor raises quarterly dividend 20% 12:32 p.m. Oct. 10, 2013 - MarketWatch.com
Hedge funds: Great with small caps, not shorts 11:50 a.m. Aug. 28, 2013 - The Trading Deck
Short sellers suffer worst losses in a decade 8:01 a.m. Aug. 21, 2013 - Insider Monkey
Small caps smoke bigger peers, but be careful 10:02 a.m. Aug. 8, 2013 - William L. Watts
7 gut checks before the stock market opens 6:22 a.m. Aug. 8, 2013 - Barbara Kollmeyer
In focus: Bears have another chance 8:09 p.m. Aug. 7, 2013 - Lawrence G. McMillan
U.S. benchmarks hold tightly to record territory 9:58 a.m. July 15, 2013 - Michael Ashbaugh
5 stocks insiders are betting on 11:15 a.m. June 25, 2013 - Insider Monkey
10 big short squeezes besides Tesla 1:32 p.m. May 22, 2013 - Wallace Witkowski
Charting a persistent May uptrend 10:57 a.m. May 21, 2013 - Michael Ashbaugh
Dow rattles cage on uncharted territory 9:47 a.m. March 20, 2013 - Michael Ashbaugh
Mellanox shares drop on lowered outlook 5:55 p.m. Jan. 2, 2013 - Wallace Witkowski
Thursday’s biggest gaining and declining stocks 4:54 p.m. Dec. 27, 2012 - Wallace Witkowski
'Fiscal cliff' accelerating dividend payments 12:18 p.m. Dec. 4, 2012 - MarketWatch.com
Questcor unveils new dividend, ups share buyback 10:23 a.m. Sept. 28, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 5:42 p.m. Sept. 25, 2012 - Greg Morcroft
Questcor price targets slashed again 4:42 p.m. Sept. 24, 2012 - blogs.marketwatch.com
U.S. probing Questcor promotional practices 7:14 a.m. Sept. 24, 2012 - MarketWatch.com
Questcor says U.S. probing co: reports 7:08 a.m. Sept. 24, 2012 - Greg Morcroft
Questcor shares fall 22% in preopen 7:02 a.m. Sept. 24, 2012 - Greg Morcroft

Questcor Pharmaceuticals (QCOR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Today - Zacks.com
3 Biotechs to Buy and 1 to Sell Now 5:29 a.m. Today - InvestorPlace.com
Retrophin - A Peak Under The Veneer Of 2 Recent Additions 6:27 p.m. Jan. 23, 2014 - Seeking Alpha
Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Winner 5:00 p.m. Jan. 23, 2014 - TheStreet.com
Tech, Health Care Lead Early Strength In Weekly Review 4:48 p.m. Jan. 23, 2014 - Investors Business Daily
Ventrus Biosciences (VTUS) Jumps: Stock Rises 10.9% - Tale of the Tape 9:46 a.m. Jan. 23, 2014 - Zacks.com
First Week Of March 22nd Options Trading For Questcor Pharmaceuticals (QCOR) 12:07 p.m. Jan. 22, 2014 - TheStreet.com
Why Investors Are Shrugging Off Amag Pharma's Feraheme FDA Rejection 11:54 a.m. Jan. 22, 2014 - TheStreet.com
Under Obamacare, Risks Grow for High-Margin Drug Stocks 5:45 a.m. Jan. 22, 2014 - InvestorPlace.com
Shire Sells Dermagraft - Analyst Blog 4:55 p.m. Jan. 20, 2014 - Zacks.com
Questcor Presents at JPM Conference - Analyst Blog 6:34 p.m. Jan. 17, 2014 - Zacks.com
ArQule Up on Study Results - Analyst Blog 6:04 p.m. Jan. 17, 2014 - Zacks.com
3 Biotech Stocks Where Momentum is Alive and Well 8:47 a.m. Jan. 17, 2014 - InvestorPlace.com
Questcor Pharmaceuticals (QCOR) Looks Good: Stock Surges 11.2% in Session - Tale of the Tape 8:44 a.m. Jan. 17, 2014 - Zacks.com
Questcor Pharmaceuticals' CEO Presents at 32nd Annual J.P. Morgan Healthcare Conference (Transcript) 2:34 p.m. Jan. 16, 2014 - Seeking Alpha
Solid 2014 Expected for Shire - Analyst Blog 2:11 p.m. Jan. 16, 2014 - Zacks.com
Questcor CEO Updates Q4, Hints At Radical Change 1:31 p.m. Jan. 16, 2014 - Investors Business Daily
Should You Worry About the Short Interest in Questcor Pharma (QCOR)? - Tale of the Tape 6:47 a.m. Jan. 16, 2014 - Zacks.com
Tomorrow's Ex-Dividends To Watch: DHY, EDI, TK, QCOR 10:00 a.m. Jan. 14, 2014 - TheStreet.com
Questcor: Continued Strong Earnings Will Drive It Over $90 - Part II 3:39 a.m. Jan. 14, 2014 - Seeking Alpha

Questcor Commits $500,000 to Launch of Questcor Research Fellowship Program for 2014 7:00 a.m. Jan. 22, 2014 - PR Newswire - PRF
Critical Alerts For SolarCity, QualComm, Questcor Pharmaceuticals, Dollar General, and Organovo Released By InvestorsObserver 9:31 a.m. Jan. 17, 2014 - PR Newswire - PRF
Questcor Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference 6:30 a.m. Jan. 8, 2014 - PR Newswire
Pre-Market Highlight of the Day: Questcor Pharma, PDL BioPharma, Amgen, and BioCryst Pharma 8:00 a.m. Jan. 3, 2014 - PR Newswire
Completed Purchases, Ratings Upgrade, Results Presentation, Dividend Declaration, and Conference Participation - Research Report on NHI, HTA, AmerisourceBergen, Questcor, and Thoratec 8:00 a.m. Dec. 31, 2013 - PR Newswire
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 8:00 a.m. Dec. 20, 2013 - PR Newswire
Important Trend Analysis: Tesla Motors Inc, Federal National Mortgage Association, WPCS International Incorporated, Questcor Pharmaceuticals Inc 11:16 a.m. Dec. 19, 2013 - ACCESSWIRE
Notable Buzzers: Questcor Pharmaceuticals, Omeros Corporation, BioCryst Pharmaceuticals, Baidu Inc 10:36 a.m. Dec. 18, 2013 - ACCESSWIRE
Questcor Provides Donation In Support Of Children's Hospital & Research Center Oakland 4:00 p.m. Dec. 17, 2013 - PR Newswire
Partnerships, Appointments, New Products, Public Offerings, and Agreements - Research Report on Questcor Pharmaceuticals, Hologic, IDEXX, Endologix, and Healthways 8:00 a.m. Dec. 13, 2013 - PR Newswire
Questcor Announces Quarterly Cash Dividend and Provides Update on Share Repurchase Program 7:00 a.m. Dec. 11, 2013 - PR Newswire
Questcor and Child Neurology Foundation Support the 5th Annual Infantile Spasms Awareness Week 6:30 a.m. Dec. 9, 2013 - PR Newswire
Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference 5:56 p.m. Dec. 5, 2013 - PR Newswire
Biologics License Applications, Event Participations, and Stock Movements - Research Report on Baxter, WellPoint, Questcor Pharmaceuticals, CareFusion, and Hologic 8:00 a.m. Dec. 5, 2013 - PR Newswire
Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare 8:00 a.m. Nov. 27, 2013 - PR Newswire
Questcor Honored as an "Everyday Hero" by NephCure Foundation 7:00 a.m. Nov. 22, 2013 - PR Newswire
Biotech Companies Announce Upcoming Conferences, Appointments - Research Report on Illumina, Epizyme, Questcor Pharmaceuticals, Infinity, and Endocyte 8:00 a.m. Nov. 19, 2013 - PR Newswire
Questcor Adds G. Kelly Martin to Board of Directors 4:25 p.m. Nov. 12, 2013 - PR Newswire
New Appointments, Financial Results, Dividends, and Presentations - Research Report on WellPoint, Perrigo, Health Net, Zoetis, and Questcor 8:00 a.m. Nov. 12, 2013 - PR Newswire
Before the Bell Scans: PDL BioPharma Inc., Amgen Inc., Questcor Pharma Inc., and BioCryst Pharma Inc. 12:24 p.m. Nov. 8, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HSBC Unveils $1B Tender Offer to Manage Capital Base

HSBC's Strategic Capital Maneuver Alright, let's chew on this one: HSBC's out to repurchase up to a cool billion bucks worth of its own security paper. We're talking about the $3 billion, 6% Perpetual Subordinated Contingent Convertible Securities, which can be called up as soon as May 2027. Now, they're not going all-in—the offer is capped at $1 billion, though the...

NACCO Navigates Strong 2026 Q3, Faces Solar Cost Hurdles

Rolling With NACCO's Financial Punches Well, folks, when it rains, it pours—numbers that is. NACCO Industries just laid out their Q3 results for all to gawk at, and it's a mixed bag of triumphs and tussles. You got a gross profit of $11.8 million, a sweet 18% jump on the same quarter last year. Now, you're talking about revenue muscle, and there it is. Income before...

Construction Partners' Georgia Move Bolsters Growth

CPI's Strategic Expansion into Georgia Here's an acquisition to keep your eye on: Construction Partners, Inc. (NASDAQ: ROAD), also known in the corridors of trading as CPI, is making a move that many of us in the business have been anticipating for some time. They’ve wrapped up the acquisition of Piedmont Paving, Inc., a Newnan, Georgia-based company. Now, for most...

International Book Launch Celebrates Chinese Garden Art

Book Celebrates the Harmony of Nature and Culture The dusty pages of history crack open yet again, but this time with an aromatic whiff of oriental garden artistry. Some might say books and gardens don't share much beyond paper, mulch, and soil. But hold tight. This isn't just any old launch—it's the Harmony Between the Universe: International Perspectives on the Lion...

LIME Faces Investigation Amid Earnings Shortfall

Financial Miss Spurs Investigation When you've been in this racket as long as I have, you learn that missing consensus earnings even by a few cents can stir up a financial hornet's nest. That's precisely where Neutron Holdings Inc., better known as Lime, finds itself. With their third-quarter earnings slipping two cents below expectation, at $0.63 against a $0.66 to $0.68...

Atlas Ocean Expands with New Epic Journeys for 2027-28

Atlas Ocean Voyages' Grand Plans Anyone who's been sailing this rocky market sea long enough knows there’s no better place to gauge the winds than from a cozy captain's chair—so picture this: Atlas Ocean Voyages just dropped a 2027-28 roadmap that’s more of an atlas in its own right. We’re talking epic voyages spanning Europe, the Med, and Arctic realms, all while...

Utility Returns: Short-Term Savings, Long-Term Costs

Crunching the Numbers on Utility Returns There's a buzz in the utility sector, and it's not just the hum of power lines—it’s all about return on equity (ROE). Concentric Energy Advisors just dropped some insights that could have us rethinking how these returns play into customer bills and utilities' financing capabilities. What's the Deal with ROE? Think of ROE like a...

Vermiculus Taps New CISO Amid Index Engine Launch

Vermiculus Ups Its Security Game You ever wonder why a company decides to beef up security? Well, Vermiculus ain't leaving anything to chance as they roll out new tech. They've named Alexander Kilian the Chief Information Security Officer. Yep, Kilian's stepping into the ring, and no one’s treating this like a sidebar gig. This market tech outfit isn't just polishing...

Cardinal Health Surges with Increased EPS Outlook

Cardinal Health's Towering Numbers and Raised Outlook Holy moly, Cardinal Health is strutting out of the gate like they mean business. Their first quarter for fiscal year 2027 showed revenue hitting a hefty $67.5 billion—up 5% from last year. If you're holding NYSE:CAH, you might be grinning ear to ear right now. Cardinal didn’t just squeeze out more revenue; they saw...

Admetec Shines Bright with New High-Magnification Headlights

Admetec's Leap into Advanced Optical Solutions In the world of optical magnification, getting the right balance of visibility and comfort hasn't always been a straightforward journey. Now, Admetec, coming out of Haifa, Israel, is throwing a game-changer into the mix with their announcement of the Butterfly EVO+ and Orchid+ series. These ain't just any old headlights;...